| For: | Kim JH, Oh CM, Yoo JH. Obesity and novel management of inflammatory bowel disease. World J Gastroenterol 2023; 29(12): 1779-1794 [PMID: 37032724 DOI: 10.3748/wjg.v29.i12.1779] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i12/1779.htm |
| Number | Citing Articles |
| 1 |
Stephanie L. Gold, Asher Kornbluth. The Role of the Gastroenterologist in Obesity Management: Now Is the Right Time for Our Involvement. American Journal of Gastroenterology 2024; 119(6) doi: 10.14309/ajg.0000000000002791
|
| 2 |
Karlijn Demers, Noortje van den Bergh, Bart C Bongers, Sander M J van Kuijk, Zlatan Mujagic, Daisy M A E Jonkers, Marieke J Pierik, Laurents P S Stassen. Health-Related Physical Fitness in Patients With Inflammatory Bowel Disease vs Healthy Control Subjects. Inflammatory Bowel Diseases 2025; 31(12) doi: 10.1093/ibd/izaf169
|
| 3 |
Chhagan L. Birda, Fadwa Ibrahim, Abhirup Chatterjee, Anuraag Jena, Vishal Sharma, Shaji Sebastian. Impact of GLP-1 analogues on immune-mediated inflammatory diseases: A systematic review. Autoimmunity Reviews 2026; 25(1) doi: 10.1016/j.autrev.2025.103936
|
| 4 |
Joonhee Han, Hyun Joo Song, Min Sook Kang, Hogyung Jun, Heung Up Kim, Ki Soo Kang, Donghyoun Lee. Micronutrient Deficiency and Muscular Status in Inflammatory Bowel Disease. Nutrients 2024; 16(21) doi: 10.3390/nu16213763
|
| 5 |
Eugeni Domènech, Andreea Ciudin, José María Balibrea, Eduard Espinet-Coll, Fiorella Cañete, Lilliam Flores, Manuel Ferrer-Márquez, Román Turró, Alejandro Hernández-Camba, Yamile Zabana, Ana Gutiérrez, José María Balibrea, Manuel Barreiro-de Acosta, Javier Butragueño, Fiorella Cañete, Andreea Ciudin Mihai, Ana B. Crujeiras, Andrés J. del Pozo-García, Eugeni Domènech, José Miguel Esteban López-Jamar, Eduard Espinet-Coll, Manuel Ferrer-Márquez, Lilliam Flores, M. Dolores Frutos, Ana Gutiérrez, Alejandro Hernández-Camba, Míriam Mañosa, Francisco Rodríguez-Moranta, Fàtima Sabench, Román Turró, Yamile Zabana. Recommendations on the management of severe obesity in patients with inflammatory bowel disease of the Spanish Group on Crohn’s Disease and Ulcerative Colitis (GETECCU), Spanish Society of Obesity (SEEDO), Spanish Association of Surgery (AEC) and Spanish Society of Digestive Endoscopy (SEED). Gastroenterología y Hepatología (English Edition) 2024; 47(8) doi: 10.1016/j.gastre.2024.04.051
|
| 6 |
Shi-Yan Zhang. Navigating new horizons in inflammatory bowel disease: Integrative approaches and innovations. World Journal of Gastroenterology 2024; 30(41): 4411-4416 doi: 10.3748/wjg.v30.i41.4411
|
| 7 |
Maolang He, Ruru Gu, Xin Huang, Aifang Zhao, Shuxin Tian, Yong Zheng. Global burden of colorectal cancer attributable to metabolic risks from 1990 to 2021, with projections of mortality to 2035. International Journal of Colorectal Disease 2025; 40(1) doi: 10.1007/s00384-025-04817-w
|
| 8 |
Yan Gong, Yishu He, Mengting Wan, Hong Chen. Risk Factors for Gallstones in Crohn’s Disease: A Systematic Review and Meta-Analysis. Digestive Diseases and Sciences 2024; 69(11) doi: 10.1007/s10620-024-08597-1
|
| 9 |
Jee Hyun Kim, Yoon Jeong Choi, Jun Hwan Yoo. Gut microbiome: a key driver and therapeutic target of intestinal fibrosis in Crohn’s disease. Intestinal Research 2026; doi: 10.5217/ir.2026.00013
|
| 10 |
I-Chen Lin, Hsien Liu. Impact of Bariatric Surgery on Outcomes of Patients with Inflammatory Bowel Disease: a Nationwide Inpatient Sample Analysis, 2005–2018. Obesity Surgery 2024; 34(2) doi: 10.1007/s11695-023-07023-1
|
| 11 |
Kijae Jo, Kwang Woo Kim, Hyun Jung Lee, Jong Pil Im, Joo Sung Kim, Seong-Joon Koh. Predictors of histologic remission in patients with biologic-naïve, moderate-to-severe ulcerative colitis treated with first-line biologic agents and small-molecule drugs: a single-center, retrospective cohort study. Intestinal Research 2024; 22(4) doi: 10.5217/ir.2024.00044
|
| 12 |
Hindol Ray, Janatum Khatum, Srijan Haldar, Priyanka Bhowmik. Second brain: reviewing the gut microbiome’s role in lifestyle diseases. BioTechnologia 2025; 106(1) doi: 10.5114/bta/195495
|
| 13 |
Laura C. Sahyoun, Jill K. J. Gaidos. Weighing In: The Use of Glucagon-Like Peptide-1 Receptor Agonists in Inflammatory Bowel Disease. Digestive Diseases and Sciences 2026; 71(4) doi: 10.1007/s10620-025-09515-9
|
| 14 |
Tanya Sinha, Zukhruf Zain, Syed Faqeer Hussain Bokhari, Sarosh Waheed, Taufiqa Reza, Anthony Eze-Odurukwe, Mitwa Patel, Mohammed Khaleel I KH Almadhoun , Azlaan Hussain, Ibrahim Reyaz. Navigating the Gut-Cardiac Axis: Understanding Cardiovascular Complications in Inflammatory Bowel Disease. Cureus 2024; doi: 10.7759/cureus.55268
|
| 15 |
Sara Sila, Marina Aloi, Ugo Cucinotta, Laura Gianolio, Maya Granot, Ondrej Hradsky, Séamus Hussey, Ben Kang, Anna Karoliny, Kaija-Leena Kolho, Jan de Laffolie, Sara Lega, Manar Matar, Lorenzo Norsa, Sharon Omiwole, Esther Orlanski-Meyer, Laura Palomino, Pejman Rohani, Luca Scarallo, Margaret Sladek, Mohammad Hassan Sohouli, Darja Urlep, Anat Yerushalmy-Feler, Eyal Zifman, Iva Hojsak. Effect of Overweight and Obesity on the Response to Anti-TNF Therapy and Disease Course in Children With IBD. Inflammatory Bowel Diseases 2025; 31(5) doi: 10.1093/ibd/izae165
|
| 16 |
Eugeni Domènech, Andreea Ciudin, José María Balibrea, Eduard Espinet-Coll, Fiorella Cañete, Lilliam Flores, Manuel Ferrer-Márquez, Román Turró, Alejandro Hernández-Camba, Yamile Zabana, Ana Gutiérrez, José María Balibrea, Manuel Barreiro-de Acosta, Javier Butragueño, Fiorella Cañete, Andreea Ciudin Mihai, Ana B. Crujeiras, Andrés J. del Pozo-García, Eugeni Domènech, José Miguel Esteban López-Jamar, Eduard Espinet-Coll, Manuel Ferrer-Márquez, Lilliam Flores, M. Dolores Frutos, Ana Gutiérrez, Alejandro Hernández-Camba, Míriam Mañosa, Francisco Rodríguez-Moranta, Fàtima Sabench, Román Turró, Yamile Zabana. Recomendaciones sobre el manejo de la obesidad grave en pacientes con enfermedad inflamatoria intestinal del Grupo Español de Trabajo en Enfermedad Inflamatoria Intestinal (GETECCU), Sociedad Española de Obesidad (SEEDO), Asociación Española de Cirugía (AEC) y Sociedad Española de Endoscopia Digestiva (SEED). Gastroenterología y Hepatología 2024; 47(8) doi: 10.1016/j.gastrohep.2023.12.008
|
| 17 |
M.S. Martins, G.J. Santos, C.J. Almeida, P.C. Duran, G. Couto, T.C. Morais, G.O. Santana, R. Rocha. Sarcopenia, composición corporal y fatiga: ¿existe una conexión en los pacientes con enfermedad inflamatoria intestinal?. Revista de Gastroenterología de México 2026; 91(3) doi: 10.1016/j.rgmx.2025.11.004
|
| 18 |
Jennifer Youn, Katie Hsia, Surya Khadilkar, Tanya Zeina, Puja Rai, Akash Rastogi, Sureya Hussani, Samara Spence, Pranay Adavelly, Jason Yanes, Jacob Kotlier, Benjamin Sweigart, Alexander N. Levy, Sonia Friedman. The Impact of Obesity on the Prevalence and Complications of Perianal Fistulas of Crohn’s Disease. Digestive Diseases and Sciences 2025; 70(1) doi: 10.1007/s10620-024-08729-7
|
| 19 |
Jonathan Weng, Chunmin C. Lo. Gut Hormones and Inflammatory Bowel Disease. Biomolecules 2025; 15(7) doi: 10.3390/biom15071013
|
| 20 |
Ryan Njeim, Elie Moussa, Ali Sohail, Chapman Wei, Ahmad Abou Yassine, Liliane Deeb. Metabolic Comorbidities and Hospital Outcomes in Patients With Inflammatory Bowel Disease. Journal of Clinical Gastroenterology 2026; doi: 10.1097/MCG.0000000000002333
|
| 21 |
Jiamin Zhao, Bingzhen Ji, Xvying Li, Weipeng Zhang, Junxing Zhao. Guanidinoacetic acid attenuates high-fat diet induced colitis by targeting mitophagy and the gut microbiota in middle-aged mice. Food Bioscience 2025; 68 doi: 10.1016/j.fbio.2025.106587
|
| 22 |
Lucas Dalvi Armond REZENDE, Camila ADOUR, Gabriel Confalonieri BERTOLDI, Marco Antônio Oliveira BRITO, Flávia Lúcia CONCEIÇÃO, Mariana Poltronieri PACHECO. EVIDENCE OF THE INFLUENCE OF GLUCAGON-LIKE PEPTIDE ANALOGS IN INFLAMMATORY BOWEL DISEASE: A SCOPING REVIEW. Arquivos de Gastroenterologia 2026; 63 doi: 10.1590/s0004-2803.24612026-028
|
| 23 |
Minjae Joo, Seungyoon Nam. Adolescent gut microbiome imbalance and its association with immune response in inflammatory bowel diseases and obesity. BMC Microbiology 2024; 24(1) doi: 10.1186/s12866-024-03425-y
|
| 24 |
Jingjing Bai, Dianne Gelien Bouwknegt, Rinse Karel Weersma, Gerard Dijkstra, Kimberley Wilhelmina Johanna van der Sloot, Eleonora Anna Margaretha Festen. Gene-Environment Interactions in Inflammatory Bowel Disease: A Systematic Review of Human Epidemiologic Studies. Journal of Crohn's and Colitis 2025; 19(6) doi: 10.1093/ecco-jcc/jjaf061
|
| 25 |
Jun Lu, Hui Xu, Jingxuan Zhang, Tianxin Cheng, Jing Zheng, Xinjun Han, Yuxin Wang, Xuxu Meng, Xiaoyang Li, Jiahui Jiang, Xue Dong, Zhenchang Wang, Zhenghan Yang, Lixue Xu. The CT-based attenuation index of peri-bowel adipose tissue can predict disease progression in inflammatory bowel disease patients. European Radiology 2025; 36(4) doi: 10.1007/s00330-025-12079-x
|
| 26 |
Tiago Lima Capela, Vítor Macedo Silva, Marta Freitas, Cátia Arieira, Tiago Cúrdia Gonçalves, Francisca Dias de Castro, Joana Magalhães, José Cotter. Identifying inflammatory bowel disease patients at risk of metabolic dysfunction-associated fatty liver disease: usefulness of non-invasive steatosis predictive scores. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02988-w
|
| 27 |
Heidi Hjelle, Tor Åge Myklebust, Atle van Beelen Granlund, Ann Elisabeth Østvik, Eivind Ness-Jensen. Changes in prevalence and incidence of inflammatory bowel disease over 30 years: a population-based cohort study, the HUNT study. Scandinavian Journal of Gastroenterology 2026; 61(1) doi: 10.1080/00365521.2025.2555920
|
| 28 |
Rúbia Moresi Vianna de Oliveira, Ana Carolina Junqueira Vasques, Stefhani Andrioli Romero, Nitin Shivappa, Michael D. Wirth, James R. Hébert, Glaucia Fernanda Soares Ruppert Reis, Cristiane Kibune Nagasako. Dietary inflammatory index and objective disease activity in IBD: no association found. European Journal of Clinical Nutrition 2026; 80(5) doi: 10.1038/s41430-026-01713-6
|
| 29 |
Irving Levine, Shaina Sekhri, William Schreiber-Stainthorp, Brandon Locke, Olivia Delau, Mohamed Elhawary, Krutika Pandit, Xucong Meng, Jordan Axelrad. GLP-1 Receptor Agonists Confer No Increased Rates of IBD Exacerbation Among Patients With IBD. Inflammatory Bowel Diseases 2025; 31(2) doi: 10.1093/ibd/izae250
|
| 30 |
Kate Phuong-Nguyen, Malik Mahmood, Leni Rivera. Deleterious Effects of Yoyo Dieting and Resistant Starch on Gastrointestinal Morphology. Nutrients 2024; 16(23) doi: 10.3390/nu16234216
|
| 31 |
Michael Saadeh, Apoorva Krishna Chandar, Revital Gorodeski Baskin, Jeffry Katz, Fabio Cominelli, Emad Mansoor, Miguel Regueiro, Vu Quang Nguyen, Than Than Aye. Glucagon‐Like Peptide‐1 Receptor Agonists Are Associated With Improved Outcomes in Inflammatory Bowel Disease. GastroHep 2026; 2026(1) doi: 10.1155/ygh2/2239686
|
| 32 |
George Safwat Riad, Tarek Maged Elsakaty, Khaled Mohamed Raafat, Ibraheem Magdy Ibraheem, Youmna Nader Mohamed Eldamhogy, Mohamed Gamal Youssef. Colonoscopic and histopathological findings in obese patients with fibroscan-detected hepatic steatosis: a cross-sectional study. Egyptian Liver Journal 2026; 16(1) doi: 10.1186/s43066-026-00557-w
|
| 33 |
Joëlle St-Pierre, Jeremy Klein, Natalie K. Choi, Evan Fear, Silvana Pannain, David T. Rubin. Efficacy and Safety of GLP-1 Agonists on Metabolic Parameters in Non-diabetic Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences 2024; 69(12) doi: 10.1007/s10620-024-08720-2
|
| 34 |
María Dolores Herrera, Antoni Aguiló, Pedro Tauler, José Antonio Mingorance, Daniel Ginard, Eva Puchol, Sonia Martínez. High prevalence of fatigue in patients with inflammatory bowel disease: association with physical activity intensity and sedentary behavior. Frontiers in Public Health 2026; 14 doi: 10.3389/fpubh.2026.1893458
|
| 35 |
Youbao Zhong, Qiuping Xiao, Jiaqi Huang, Songren Yu, Liling Chen, Qi Wan, Zheyan Zhang, Lin Luo, Lizhao Song, Haimei Zhao, Wen Zhou, Duanyong Liu. Ginsenoside Rg1 Alleviates Ulcerative Colitis in Obese Mice by Regulating the Gut Microbiota–Lipid Metabolism–Th1/Th2/Th17 Cells Axis. Journal of Agricultural and Food Chemistry 2023; 71(50) doi: 10.1021/acs.jafc.3c04811
|
| 36 |
Karolina Wyka, Mirza Farhana Iqbal Chowdhury, Farzad Mokhtari-Esbuie, Amid Yazdani, Jakub Fichna. Abdominal Pain. 2026; doi: 10.1016/B978-0-443-41638-5.00012-0
|
| 37 |
Wissam Ghusn, Edward V. Loftus, Amanda M. Johnson. Reviewing the impact of obesity on inflammatory bowel disease and considerations for optimizing management. Current Opinion in Gastroenterology 2024; 40(4) doi: 10.1097/MOG.0000000000001025
|
| 38 |
Young Jin Lee, Eun Ja Kwon, Da-In Park, Sang Hyoung Park, Sung Wook Hwang, Byong Duk Ye. Effectiveness of an app-based walking program for obese patients with inflammatory bowel disease in Korea: a single-blind parallel-group randomized clinical trial. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03962-4
|
| 39 |
Bhaskaranand Pancholi, Amarjeet Rao, Debapriya Garabadu. Drug Repurposing: Exploring Newer Therapeutic Potentials. 2026; doi: 10.1007/978-981-95-4522-3_7
|
| 40 |
Michał Święch, Justyna Lorenc-Góra, Małgorzata Muc-Wierzgoń, Elżbieta Świętochowska, Paweł Kowalczyk, Zenona P. Czuba, Dariusz Waniczek. Serum Cytokine Profiles Associated with Inflammation and Tumor Progression in Crohn’s Disease and Colorectal Cancer. International Journal of Molecular Sciences 2026; 27(5) doi: 10.3390/ijms27052156
|
| 41 |
Dilek Sivri, Betül Şeref, Melike Şare Bulut, Makbule Gezmen Karadağ. Evaluation of the Effect of Probiotic Supplementation on Intestinal Barrier Integrity and Epithelial Damage in Colitis Disease: A Systematic Review. Nutrition Reviews 2025; 83(7) doi: 10.1093/nutrit/nuae180
|
| 42 |
Staffan Hildebrand, Alexander Pfeifer. The obesity pandemic and its impact on non-communicable disease burden. Pflügers Archiv - European Journal of Physiology 2025; 477(5) doi: 10.1007/s00424-025-03066-8
|
| 43 |
Diego Casas-Deza, Santiago García-López, Vanesa Bernal-Monterde, Cristina Polo-Cuadro, Carmen Yagüe-Caballero, José M. Arbones-Mainar. Obesity-Mediated Inflammation and Its Influence on Inflammatory Bowel Disease: Pathophysiology, Clinical Impact, and Therapeutic Implications. Biomolecules 2025; 15(8) doi: 10.3390/biom15081185
|
| 44 |
Andres J. Yarur, Millie D. Long, Joana Torres, Neilanjan Nandi, Raymond K. Cross, Arcangelo M. Abbatemarco, David Blanco, Wojciech Niezychowski, Catherine Crosby, Joseph Wu, Gokul Pradeep, Martina Goetsch, Remo Panaccione. Body Mass Index Did Not Affect Efficacy and Safety of Etrasimod: A Post Hoc Analysis of the ELEVATE Ulcerative Colitis Clinical Program. American Journal of Gastroenterology 2025; 120(11) doi: 10.14309/ajg.0000000000003330
|
| 45 |
Jellyana Peraza, Erin Abbott, Mark Shneyderman, Asher Kornbluth, Maitreyi Raman, Stephanie Gold. The Rising Epidemic of Obesity in Patients with Inflammatory Bowel Disease. Current Treatment Options in Gastroenterology 2024; 22(3) doi: 10.1007/s11938-024-00453-5
|
| 46 |
Dured Dardari. GLP-1 receptor agonists at the crossroads of metabolic and gut inflammation: Implications for people with type 2 diabetes and inflammatory bowel disease. Therapeutic Advances in Endocrinology and Metabolism 2026; 19 doi: 10.1177/20420188261478400
|
| 47 |
Razan Algarni, Efstathia Papada, Adrian Brown. Inflammatory Bowel Disease in Children and Young People Living With Overweight or Obesity: A Critical Narrative Review. Obesity Reviews 2026; 27(5) doi: 10.1111/obr.70063
|
| 48 |
Wafa A. Aldhaleei, Tarek Odah, Nader Bakheet, Heather Jett, Jana G. Hashash, Michael B. Wallace, Vivek Kumbhari, Francis A. Farraye, Akshaya Srikanth Bhagavathula. New Onset Inflammatory Bowel Disease Risk Following Bariatric Surgery: A Systematic Review and Meta-Analysis of Observational Studies. Gastroenterology Insights 2024; 15(3) doi: 10.3390/gastroent15030050
|
| 49 |
Jun Lu, Hui Xu, Jing Zheng, Tianxin Cheng, Xinjun Han, Yuxin Wang, Xuxu Meng, Xiaoyang Li, Jiahui Jiang, Xue Dong, Xijie Zhang, Zhenchang Wang, Zhenghan Yang, Lixue Xu. Increased CT Attenuation of Pericolic Adipose Tissue as a Noninvasive Marker of Disease Severity in Ulcerative Colitis. Korean Journal of Radiology 2025; 26(5) doi: 10.3348/kjr.2024.0857
|
| 50 |
Haoxue Zhu, Xinghao Yi, Mengyu He, Siyi Wu, Ming Li, Shan Gao. Childhood Obesity and Age‐Related Diseases: A Systematic Review and Meta‐Analysis of Mendelian Randomization Evidence. Pediatric Obesity 2026; 21(1) doi: 10.1111/ijpo.70071
|
| 51 |
Jiao Xie, Yan Ling, Shi Wang, Rui Gong. Obesity: An Overlooked Factor in Inflammatory Bowel Disease. International Journal of Molecular Sciences 2026; 27(9) doi: 10.3390/ijms27093911
|
| 52 |
Duc-Vinh Pham, Thi-Kem Nguyen, Bao-Loc Nguyen, Jong-Oh Kim, Jee-Heon Jeong, Inho Choi, Pil-Hoon Park. Adiponectin restores the obesity-induced impaired immunomodulatory function of mesenchymal stromal cells via glycolytic reprogramming. Acta Pharmaceutica Sinica B 2024; 14(1) doi: 10.1016/j.apsb.2023.10.019
|
| 53 |
Carlo Redavid, Pietro Pirro, Luisa Bertin, Edoardo V. Savarino. Impact of Obesity and Its Treatment on Inflammatory Bowel Disease Outcomes: A Narrative Review. Gastroenterology Insights 2026; 17(4) doi: 10.3390/gastroent17040057
|
| 54 |
Yunhao Yang, Fang Pang, Min Zhou, Xiao Guo, Yan Yang, Wei Qiu, Cai Liao, Yang Chen, Chenglin Tang. Electroacupuncture Reduces Inflammatory Bowel Disease in Obese Mice by Activating the Nrf2/HO-1 Signaling Pathways and Repairing the Intestinal Barrier. Diabetes, Metabolic Syndrome and Obesity 2024; doi: 10.2147/DMSO.S449112
|
| 55 |
Jun Lu, Hui Xu, Haiyun Shi, Jing Zheng, Tianxin Cheng, Minsi Zhou, Xinjun Han, Yuxin Wang, Xuxu Meng, Xiaoyang Li, Jiahui Jiang, Peng Li, Zhenghan Yang, Lixue Xu. Computed tomography-based body composition parameters can predict short-term prognosis in ulcerative colitis patients. Insights into Imaging 2024; 15(1) doi: 10.1186/s13244-024-01615-w
|
| 56 |
Yoon Jeong Choi, Woo Ram Kim, Duk Hwan Kim, Jee Hyun Kim, Jun Hwan Yoo. Human umbilical cord/placenta mesenchymal stem cell conditioned medium attenuates intestinal fibrosis in vivo and in vitro. Stem Cell Research & Therapy 2024; 15(1) doi: 10.1186/s13287-024-03678-4
|
| 57 |
Krisadelfa Sutanto, Diana Sunardi, Jessica Ferdi. Nutrition-Related Factors in Inflammatory Bowel Disease: Modulating Inflammation through Clinical Management. International Journal of Nutrition, Pharmacology, Neurological Diseases 2026; 16(2) doi: 10.4103/ijnpnd.ijnpnd_19_26
|
| 58 |
Athanasios Migdanis, Ioannis Migdanis, Nikoleta D. Gkogkou, Sousana K. Papadopoulou, Constantinos Giaginis, Athanasios Manouras, Maria Anna Polyzou Konsta, Rena I. Kosti, Konstantinos A. Oikonomou, Konstantinos Argyriou, Spyridon Potamianos, Andreas Kapsoritakis. The Relationship of Adherence to the Mediterranean Diet with Disease Activity and Quality of Life in Crohn’s Disease Patients. Medicina 2024; 60(7) doi: 10.3390/medicina60071106
|
| 59 |
Daye Park, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Hee Cheon. Impact of body mass index on clinical outcomes in intestinal Behçet’s disease. The Korean Journal of Internal Medicine 2025; 40(4) doi: 10.3904/kjim.2024.349
|
| 60 |
Mohammad Reza Pour Salehi, Jalil Reisi, Sayed Mohammad Marandi, Milad Abdollahi. Effect of Whole-Body Electrical Muscle Stimulation Training on Inflammatory and Anti-inflammatory Cytokines in Overweight Men. Journal of Obesity & Metabolic Syndrome 2024; 33(3) doi: 10.7570/jomes23070
|
| 61 |
Robert M. MacGregor, Shaina R. Eckhouse. The SAGES Manual of Metabolic and Bariatric Surgery. 2024; doi: 10.1007/978-3-031-72309-4_50
|